145 related articles for article (PubMed ID: 30539866)
1. Meta-analysis on the association between xeroderma pigmentosum Group A A23G polymorphism and esophageal cancer in a Chinese population.
Xu JL; Bai J; Jiao JF; Ding L; Lei L; Bai XP; Cheng YF
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1173-S1177. PubMed ID: 30539866
[TBL] [Abstract][Full Text] [Related]
2. XPA A23G polymorphism and susceptibility to cancer: a meta-analysis.
Liu J; Zhang Z; Cao XL; Lei DP; Wang ZQ; Jin T; Pan XL
Mol Biol Rep; 2012 Jun; 39(6):6791-9. PubMed ID: 22314912
[TBL] [Abstract][Full Text] [Related]
3. XPA A23G polymorphism and risk of digestive system cancers: a meta-analysis.
He L; Deng T; Luo H
Onco Targets Ther; 2015; 8():385-94. PubMed ID: 25709470
[TBL] [Abstract][Full Text] [Related]
4. XPA A23G polymorphism and lung cancer risk: a meta-analysis.
Zou JH; An L; Chen S; Ren LQ
Mol Biol Rep; 2012 Feb; 39(2):1435-40. PubMed ID: 21611749
[TBL] [Abstract][Full Text] [Related]
5. Association between XPA gene rs1800975 polymorphism and susceptibility to lung cancer: a meta-analysis.
Liu X; Lin Q; Fu C; Liu C; Zhu F; Liu Z; Li S; Jiang L
Clin Respir J; 2018 Feb; 12(2):448-458. PubMed ID: 27460688
[TBL] [Abstract][Full Text] [Related]
6. Association of XPA Polymorphisms Towards Lung Cancer Susceptibility and its Predictive Role in Overall Survival of North Indians.
Lawania S; Singh N; Behera D; Sharma S
Biochem Genet; 2018 Aug; 56(4):375-396. PubMed ID: 29516319
[TBL] [Abstract][Full Text] [Related]
7. Association of the
Wu L; Gao X; Ye D; Ding Y; Yang XI; Liu W
Mol Clin Oncol; 2015 May; 3(3):649-654. PubMed ID: 26137282
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation of XPA gene and risk of cancer: a systematic review and pooled analysis.
Ding D; Zhang Y; Yu H; Guo Y; Jiang L; He X; Ma W; Zheng W
Int J Cancer; 2012 Jul; 131(2):488-96. PubMed ID: 21866550
[TBL] [Abstract][Full Text] [Related]
9. [The relationship between polymorphism of genes XPA, XPC, XPD, XRCC1 and susceptibility to acute lymphoblastic leukemia].
Tang FF; Ouyang J; Xu Y; Zhou RF; Zhou M; Chen B; Zhang QG; Feng X; Zhang X; Chen MM; Zeng Y; Xu YY
Zhonghua Nei Ke Za Zhi; 2011 Oct; 50(10):859-62. PubMed ID: 22321329
[TBL] [Abstract][Full Text] [Related]
10. Potential risk of esophageal squamous cell carcinoma due to nucleotide excision repair XPA and XPC gene variants and their interaction among themselves and with environmental factors.
Rafiq R; Bhat GA; Lone MM; Masood A; Dar NA
Tumour Biol; 2016 Aug; 37(8):10193-207. PubMed ID: 26831662
[TBL] [Abstract][Full Text] [Related]
11. Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.
Yang R; Zhang C; Malik A; Shen ZD; Hu J; Wu YH
World J Gastroenterol; 2014 Nov; 20(44):16765-73. PubMed ID: 25469049
[TBL] [Abstract][Full Text] [Related]
12. Association of XPA polymorphism with breast cancer risk: A meta-analysis.
Zhang Y; Guo Q; Yin X; Zhu X; Zhao L; Zhang Z; Wei R; Wang B; Li X
Medicine (Baltimore); 2018 Jun; 97(26):e11276. PubMed ID: 29953005
[TBL] [Abstract][Full Text] [Related]
13. Association Studies of CYP1A1 Exon7 Polymorphism and -GSTM1 Interaction with Esophageal Cancer Risk: a Meta-Analysis in the Chinese Population.
Chen XP; Xu DF; Xu WH; Ma ZC; Yao J; Fu SM
Clin Lab; 2016 Sep; 62(9):1795-1802. PubMed ID: 28164573
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of the DNA repair gene xeroderma pigmentosum groups A and C and risk of esophageal squamous cell carcinoma in a population of high incidence region of North China.
Guo W; Zhou RM; Wan LL; Wang N; Li Y; Zhang XJ; Dong XJ
J Cancer Res Clin Oncol; 2008 Feb; 134(2):263-70. PubMed ID: 17653764
[TBL] [Abstract][Full Text] [Related]
15. XPA, haplotypes, and risk of basal and squamous cell carcinoma.
Miller KL; Karagas MR; Kraft P; Hunter DJ; Catalano PJ; Byler SH; Nelson HH
Carcinogenesis; 2006 Aug; 27(8):1670-5. PubMed ID: 16513681
[TBL] [Abstract][Full Text] [Related]
16. Pterygium and genetic polymorphisms of the DNA repair enzymes XRCC1, XPA, and XPD.
Chiang CC; Tsai YY; Bau DT; Cheng YW; Tseng SH; Wang RF; Tsai FJ
Mol Vis; 2010 Apr; 16():698-704. PubMed ID: 20431719
[TBL] [Abstract][Full Text] [Related]
17. XPD Lys751Gln polymorphism and esophageal cancer risk: a meta-analysis involving 2288 cases and 4096 controls.
Yuan L; Cui D; Zhao EJ; Jia CZ; Wang LD; Lu WQ
World J Gastroenterol; 2011 May; 17(18):2343-8. PubMed ID: 21633601
[TBL] [Abstract][Full Text] [Related]
18. PLCE1 rs2274223 A>G polymorphism and cancer risk: a meta-analysis.
Umar M; Upadhyay R; Mittal B
Tumour Biol; 2013 Dec; 34(6):3537-44. PubMed ID: 23797815
[TBL] [Abstract][Full Text] [Related]
19. The effect of XPD polymorphisms on digestive tract cancers risk: a meta-analysis.
Du H; Guo N; Shi B; Zhang Q; Chen Z; Lu K; Shu Y; Chen T; Zhu L
PLoS One; 2014; 9(5):e96301. PubMed ID: 24787743
[TBL] [Abstract][Full Text] [Related]
20. A pooled analysis of the ERCC2 Asp312Asn polymorphism and esophageal cancer susceptibility.
Wen F; Zhao Z; Liu C; Yin Q; Weng J; Wang Y; Ma Y
Tumour Biol; 2014 Apr; 35(4):2959-65. PubMed ID: 24234258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
